We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

National Survey on Coronary Patients and Heart Failure Performed in 2 Patient Groups (COMPAR)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00699959
First Posted: June 18, 2008
Last Update Posted: August 6, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
AstraZeneca
  Purpose
The purpose of this observational study is to compare frequency of attainment control goals through the more represented cardiovascular factor risk, dyslipidemia, among coronary patients with or without heart failure in cardiology consulting.

Condition
Coronary Patients Heart Failure

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Comparison and Description of Coronary Patients Management With or Without Heart Failure in Cardiology Consulting

Resource links provided by NLM:


Further study details as provided by AstraZeneca:

Primary Outcome Measures:
  • Frequency of attainment control goals through the more represented cardiovascular factor risk, dyslipidemia, among coronary patients with or without heart failure in cardiology consulting. [ Time Frame: Once ]

Enrollment: 1650
Study Start Date: June 2008
Study Completion Date: January 2009
Groups/Cohorts
1
patients with heart failure
2
patients without heart failure

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
First two consecutive Coronary patients with or without heart failure
Criteria

Inclusion Criteria:

  • patient with coronary disease diagnosed since at least 1 year
  • Echocardiography done less than 1 year ago
  • patient with or without documented heart failure

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00699959


  Show 343 Study Locations
Sponsors and Collaborators
AstraZeneca
Investigators
Study Director: Alain Castaigne AstraZeneca
  More Information

Responsible Party: Alain Castaigne, Medical Director, AstraZeneca Pharmaceuticals
ClinicalTrials.gov Identifier: NCT00699959     History of Changes
Other Study ID Numbers: NIS-CFR-DUM-2007/8
First Submitted: June 16, 2008
First Posted: June 18, 2008
Last Update Posted: August 6, 2009
Last Verified: August 2009

Keywords provided by AstraZeneca:
Coronary patients
heart failure
dyslipidemia

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases